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Abstract
Background: Reversible modification of proteins through the attachment of ubiquitin or ubiquitin-like modifiers is an
essential post-translational regulatory mechanism in eukaryotes. The conjugation of ubiquitin or ubiquitin-like proteins has
been demonstrated to play roles in growth, adaptation and homeostasis in all eukaryotes, with perturbation of ubiquitin-
mediated systems associated with the pathogenesis of many human diseases, including cancer and neurodegenerative
disorders.
Methodology/Principal Findings: Here we describe the use of an HMM search of functional Pfam domains found in the key
components of the ubiquitin-mediated pathway necessary to activate and reversibly modify target proteins in eight
apicomplexan parasitic protozoa for which complete or late-stage genome projects exist. In parallel, the same search was
conducted on five model organisms, single-celled and metazoans, to generate data to validate both the search parameters
employed and aid paralog classification in Apicomplexa. For each of the 13 species investigated, a set of proteins predicted
to be involved in the ubiquitylation pathway has been identified and demonstrates increasing component members of the
ubiquitylation pathway correlating with organism and genome complexity. Sequence homology and domain architecture
analyses facilitated prediction of apicomplexan-specific protein function, particularly those involved in regulating cell
division during these parasite’s complex life cycles.
Conclusions/Significance: This study provides a comprehensive analysis of proteins predicted to be involved in the
apicomplexan ubiquitin-mediated pathway. Given the importance of such pathway in a wide variety of cellular processes,
our data is a key step in elucidating the biological networks that, in part, direct the pathogenicity of these parasites resulting
in a massive impact on global health. Moreover, apicomplexan-specific adaptations of the ubiquitylation pathway may
represent new therapeutic targets for much needed drugs against apicomplexan parasites.
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Introduction
Apicomplexans are obligate protozoa intracellular parasites
responsible for several major human diseases prevalent in the
developing world. These include organisms belonging to the
genera Plasmodium, Toxoplasma and Cryptosporium. Toxoplasma gondii
and Cryptosporium parvum are the etiological agents of toxoplasmosis
and cryptosporidiosis, respectively, which are predominantly
opportunistic infectious agents responsible for severe mortality
amongst immuno-suppressed patients such as those infected with
HIV. The human malarial parasite Plasmodium falciparum, which is
responsible for over a million deaths annually [1], is perhaps the
most significant apicomplexan parasitic organism. The global
impact, both in terms of mortality and morbidity, of apicomplexan
parasites is currently on the rise, principally due to the increase of
drug resistant strains. For example, P. falciparum has evolved
resistance to many front-line antimalarial drugs [2] and with
apparently limited prospects in the delivery of new safe, effective
and cheap antimalarial drugs, little immediate respite is likely.
There is clearly an urgent need to characterize and validate new
drug targets, effective not only against P. falciparum but other
apicomplexan parasites as well.
Genome sequencing projects are available for several apicom-
plexan parasites, with many of them completed. The full genome
sequence of the human malarial parasite P. falciparum and the
rodent malaria parasites P. yoelii, P. berghei and P. chabaudi have
been published [3,4], with that of the human malarial parasite P.
vivax well underway. In addition, the complete annotated genomes
of T. gondii, C. parvum and Cryptosporium hominis have been recently
released [5,6]. Post genomic technologies, such as comparative
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analyses have created a vast amount of information pertaining
to gene and protein sequence/structure prediction, interspecies
identification of ortholog or paralog genes as well as temporal and
developmentally associated patterns of mRNA and protein
accumulation [7–13]. Together these studies have greatly
advanced our understanding of gene expression throughout these
parasites’ complex life cycles in various host cells and insect
vectors. Moreover, comparative analyses may provide key data
regarding protein networks, and their potential as novel drug
targets. For example, apicomplexan parasites, unlike higher
eukaryotes, utilize the non-mevalonate pathway to synthesise
isoprenoids [14]. Inhibitors of one of the key initial enzymes in this
pathway, 1-deoxy-D-xylulose 5-phosphate, such as the herbicide
fosmidomycin in combination with clindamycin, are currently
being evaluated for treatment of uncomplicated P. falciparum
malaria [15]. These data indicate the importance of comparative
genomics in evaluating the potential for novel drug targets in
apicomplexan parasites.
Here we describe a comparative analysis of one of the essential
post-translational regulatory networks commonly found in eu-
karyotic cells–the ubiquitin/proteasome system (UPS). Modifica-
tion of proteins via covalent conjugation to ubiquitin (or more
often polyubiquitin chains) is a well-established signal for
proteosomal destruction [16]. In the early 1980s, the key role of
ubiquitin in the selective pathway for degradation of proteins was
demonstrated, which was followed over the next two decades by
additional roles in a wide range of cellular processes. In addition to
ubiquitin, ubiquitin-like proteins (UBLps) have also been identified
as modifiers of cellular processes [17,18]. Together, ubiquitin and
UBLps provide a reversible modification that regulates a wide
range of cellular activities including DNA repair, transcription,
cellular division, endocytosis, intracellular trafficking and the
immune response. Importantly, defects in this pathway are
associated with human diseases, including cancer and neurode-
generative disorders such as Parkinson’s disease. By targeting
disease-specific components of the UPS, several potential new
drugs for cancer and neurodegenerative are currently under
development. The potential to chemically target the UPS in the
treatment of P. falciparum has been established [19–21]. However,
this work focuses on the inhibition of the proteasome and the
therapeutic window between the apicomplexa and the host
proteasomes may be limited. Inhibition of apicomplexan-specific
components of the enzymatic cascade that process, activate and
transfer ubiquitin and UBLps to their various protein targets may
offer attractive alternative targets.
Specificity in the conjugation of ubiquitin and ubls to their final
target is elegantly achieved via an activation and transfer cascade
[22] (figure 1). Ubiquitin-activating enzymes (termed E1) exist for
ubiquitin and each UBLp. These typically adenylate the terminal
glycine residue of ubiquitin/UBLp and transfers it to an internal
cysteine residue with the formation of a thioester bond. The
activated ubiquitin/UBLp is trans-esterified to an ubiquitin
conjugating protein (termed E2). Whereas several E2 proteins
are capable of accepting an activated ubiquitin molecule, typically
only one E2 exists for each of the UBLps characterized thus far.
Finally, ubiquitin ligases (termed E3) catalyze the transfer of
ubiquitin/ubl from E2 to a lysine side chain on a specific target
protein (this may occur directly or indirectly via conjugation to the
E3) to form an isopeptide bond. Since ubiquitin contains several
lysine residues, it can itself be ubiquitinylated, leading to the
formation of polyubiquitin chains. Differences in affinity for
ubiquitin/UBLp by the component parts of the cascade, as well as
a hierarchical increase in the numbers of these proteins (e.g. there is
one E1 for ubiquitin, several E2s and an increasing number of
characterized E3s), drive the transfer of ubiquitin/UBLp through
the cascade with the final target specificity mediated through the
E3 complex.
Ubiquitin, a highly conserved 76 amino acid peptide, was first
described in 1974 [16]. From the late 1970’s onwards, a number of
UBLps have also been described. These proteins do not share
extensive primary sequence homology with ubiquitin, but rather
share a common tertiary structure (the ubiquitin fold) and
activation/conjugation mechanism through variant E1, E2 and
E3 proteins. To date, within mammalian systems, over 10 UBLps
have been described, including interferon-stimulated gene 15
(ISG-15), neuronal precursor cell expressed developmentally down
regulated 8 (NEDD8), and small ubiquitin-related modifier
(SUMO) [23].
Analysis of the E1-activating enzymes indicates that they share
sequence homology to MoeB/ThiF domains of prokaryotic
biosynthetic proteins involved in sulphur donor systems [24].
These proteins similarly rely on an initial adenylation of a peptide
with a C-teminal diglycine motif. E1 proteins either have two
MoeB/ThiF domains necessary for the adenylation and subse-
quent internal transfer to form a thiolester bond or are a complex
of two heterodimers that each contains one MoeB/ThiF domain.
Selection of an E2 for transfer the UBL modifier via a
transesterification reaction relies on additional motifs present in
E1. The E2 protein contains a single motif that mediates
interaction with both E1 and E3, signifying the ‘‘shuttle’’ status
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Figure1.Representationofthe ubiquitin-mediated pathways.(1)
Ubiquitin is activated by E1 ubiquitin-activating enzyme, and (2)
transferred to E2 ubiquitin-conjugating enzyme. Then, ubiquitin is either
transferred to a monomeric E3 ubiquitin ligase that catalyzes ubiquityla-
tion of the target substrate (3), or ubiquitinated E2 forms associates with
the E3 to catalyze ubiquitylation of the substrate (39). Polyubiquitinated
substrate can be targeted to the proteasome and destroyed (4). Poly or
monoubiquitylation can also be an activation/repression signal (49)t h a t
modulates the substrate activity in several cellular processes such as
trafficking or chromatin modeling. Finally, deubiquitinating enzymes
(DUB) finally recycle ubiquitin proteins (5 and 59).
doi:10.1371/journal.pone.0002386.g001
Ubiquitylation in Apicomplexa
PLoS ONE | www.plosone.org 2 June 2008 | Volume 3 | Issue 6 | e2386of E2 in the transfer of ubiquitin/UBLps between activation and
subsequent ligation to their final target. E2s are present as multiple
isoforms, each with distinct roles. E2s exist for each UBL modifier,
with multiple E2s capable of accepting ubiquitin. However, even
within the ubiquitin E2 isoforms, there is functional divergence in
the specific E3s they interact with, and thus the cellular processes
they are involved in. For example, Rad6p and Cdc34p E2
isoforms deliver ubiquitin to E3s that ultimately target proteins
involved in the regulation of DNA repair and cell cycle
progression, respectively [25].
E3 ubiquitin ligases are very diverse. They have been classified
into three main classes according to the presence of specific
domain motifs: Homologous to E6-associated protein C-terminus
(HECT), Really Interesting New Proteins (RING, e.g. MDM2
known to target p53) and U-box. Two sub-classes of RINGs have
further been defined: RING in between RING-RING (RIR) and
Cullin-RING ligases (CRL), which are multi-protein complex E3s
(see [26] for a review). These CRLs are associated with proteins
carrying F-box domains, which are involved in substrate
recognition (see [27] for a review). The CRL anaphase-promoting
complex, involved in cell cycle progression, is a typical example of
an SCF-type ligase (Skp1-Cullin-Fbox). Except for the HECT
family that has a direct role in catalyzing ubiquitylation, E3s are
adaptors molecules that bring the E2 enzyme and the target
substrate into close proximity to promote ubiquitylation. The
RING finger family represents the largest group of E3s and is
characterized by a cysteine/histidine-rich/zinc chelating domain
that specifically promotes protein-protein interaction, as well as
protein-DNA binding. In eukaryotes, RING fingers have been
shown to be the key regulator of polyubiquitylation and protein
degradation. However, they have also been shown to play a pivotal
role in monoubiquitylation of substrates, independent of degrada-
tion. Monoubiquitylation has been shown to regulate events such
as the endocytosis of cell receptors (e.g. the ring finger c-Cbl is
required for the endocytosis of the Epidermal Growth factor
Receptor, EGFR), DNA-repair (ubiquitylation of p53 by the
RING finger MDM2) and transcriptional regulation (activation of
NF-kB by the RING finger TRAF6).
Conversely, de-ubiquitinylation enzymes (deubiquitinases or
DUBs) specifically remove ubiquitin/UBLps. DUBs are a large
group of cysteine proteases or zinc-dependent metalloproteases that
specifically cleave after the terminal carbonyl of the last residue of
ubiquitin adducts. Compared to the proteins involved in the
activation, conjugation and ligation of ubiquitin/UBLps relatively
little is knownaboutthe functional roleof DUBs.However,evidence
suggests that DUBs are key regulators of the ubiquitin system; DUBs
are functionally similar to protein phosphatases in the phosphory-
lation system. Based on their sequences similarities, structural studies
and potential mechanismofaction, DUBsfallinto atleast six distinct
subfamilies: the ubiquitin C-terminal hydrolases (UCH-Peptida-
se_C12), the ubiquitin specific proteases (USP-UCH), otubains
(OTU), the ataxin-3/Josephin ubiquitin protease (MJD), the JAMM
isopeptidase (Mov34) and the recent in silico prediction of the
permuted papain fold peptidase (PPPDE) [28,29]. In addition to
these DUBs subfamilies, three distinct families of deubiquitinating-
like enzymes (DUBLs) are detected in eukaryotes: the SUMO-
specific proteases (SENPs-Peptidase_C48), the autophagins (Pepti-
dase_C54), and the newly predicted WLM family of zinc-dependant
peptidases (WLM) mostly found in plants and fungi but apparently
absent in animals [29].
The UPS is known to play important roles in modulation of
immune and inflammatory responses. Deregulation of the UPS
can lead to the development of inflammatory and autoimmune
diseases, such as inflammatory arthritis, psoriasis, allergy and
asthma (see [30] for review). Proteasome inhibitors have been
developed as therapeutic molecules, principally as anticancer
drugs [31–34]. In the context of host-pathogen interactions, both
bacteria and viruses were shown to use components of their UPS
as virulence factors. The E3 ubiquitin ligase from Pseudomonas
syringae has been shown to induce sensitivity in tomato plants by
targeting a host kinase, Fen, to the proteasome, which leads to the
inhibition of the Fen-activated immunity-associated programmed
cell death [35]. The DUB SseL (from Salmonella enterica), which
causes gastroenteritis in humans, has similarly been implicated in
its virulence [36]. Components of the UPS have been shown to be
involved in many aspects of viral pathogenesis (see [37] for a
review). Two RING-finger E3 ubiquitin ligases, K3 and K5, from
herpes virus promote immune evasion by targeting MHC class 1
to ubiquitylation and endolysosomal degradation. The human
papillomavirus E6 protein interacts with the cellular E3 ubiquitin
ligase E6-associated protein. This complex mediates the protea-
some-dependant degradation of the key tumor suppressor protein
p53. DUBs have also been shown to be involved in viral
pathogenesis. In Epstein-Barr virus infection of B cells, a group
of cellular DUBs are activated, which include UCH-L1 and UCH-
L5. In adenovirus infection, the viral proteinase L3 23K is
responsible for the cleavage of viral precursor polyproteins, and
may function as a DUB [38].
These data implicate the UPS in roles from colonization,
infection, immune evasion and virulence for a range of pathogens.
To date, potential roles for the UPS in mediating similar roles for
apicomplexan parasites have yet to be explored. Here we describe
an in silico proteomic analysis of UPS from eight apicomplexan
parasites: P. falciparum, P. vivax, P. yoelii, P. berghei, P. chabaudi, C.
parvum, C. hominis, and T. gondii. Five other eukaryotic model
organisms, including Homo sapiens, Saccharomyces cerevisiae, Caenor-
habditis elegans, Drosophila melanogaster and Arabidopsis thaliana, were
analyzed in parallel for comparative purposes. We aim here to
identify and describe the most complete ubiquitylation pathway in
apicomplexan parasites, with a particular focus on Plasmodium
falciparum, highlighting those components that are specific to
apicomplexan parasites. Our results open new research perspec-
tives and are expected to pilot the development of new strategies in
the battle against these devastating apicomplexan diseases.
Results and Discussion
In silico prediction of ubiquitylation pathway
components in apicomplexan genomes
We selected 24 Pfam domains that are known to be related to
the UPS (see materials and methods section). These 24 Pfam
domains are commonly found in ubiquitin and UBLps, E1 and
E1-like enzymes, E2 enzymes, E3 enzymes and DUBs. Each Pfam
domain family was used in an hmmsearch application of the
translated genomes of Plasmodium spp. falciparum, vivax, yoelii, berghei
and chabaudi, T. gondii, Cryptosporidium spp. parvum and hominis, S.
cerevisiae, C. elegans, D. melanogaster, H. sapiens and A. thaliana. HMM
searches were run using a series of increasingly stringent threshold
E-values, from E-value #1 to E-value #0.1 (data not shown). With
regards to the five eukaryotic model organisms that were used, the
threshold E-value #0.5 gave the most consistent results when
compared to previously published results. The number of UPS-
related proteins in A. thaliana and the other model organisms has
previously been analyzed, particularly the number of E2 and E3
enzymes that are found in A. thaliana, H. sapiens, C. elegans and S.
cerevisiae (see [39–42] for reviews). The observation that our results
(table 1) are consistent with these existing data sets would appear
to validate both the HMM search strategy with a threshold E-
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model organisms for subsequent comparative analysis of the
Apicomplexa data sets.
Amongst the 13 proteomes investigated in this study, a total of
4453 proteins were identified as carrying one or more of the 24
selected Pfam domains (table 1 and supplemental Table S1). For
example, 114 proteins were found in P. falciparum, 145 in T. gondii,
114 in C. parvum and 127 in S. cerevisiae. In each case, these
numbers of UPS component proteins represent approximately
2.5% of their respective proteomes. Given the good correlation
between numbers of proteins identified in each apicomplexan with
that of the single celled model eukaryote S. cerevisiae, these data
would appear to suggest that the apicomplexan datasets are
relatively complete. For those Plasmodium species such as P. chabaudi
or P. berghei, the relative under-representation of identified proteins
would more likely reflect the completeness of the respective
genome project rather than an absolute reduction in UPS
components. The number of UPS components increases consid-
erably in multi-cellular organisms with increased genome
complexity (e.g. 678 proteins were identified in C. elegans and 883
in H. sapiens while some 1452 proteins were identified in A.
thaliana). In H. sapiens, 162 DUBs/DUBLs were found although a
previous publication only identified 95 putative DUBs/DUBLs
from which 79 exhibited conserved catalytic residues [28]. Such a
difference can be explained by the fact that proteomes extracted
from H. sapiens and D. melanogaster genomes contain multiple
isoforms for some families of DUBs and DUBLs. Furthermore, the
Hidden Markov Model that we used to search for UPS
components compiled more complete datasets than many other
search approaches would do. For example, while our HMM
search identified domain OTU-carrying proteins in apicomplexan
parasites (OTU is a major sub-class of DUB) none was reported in
a recent publication on parasitic protozoa deconjugating enzymes
where the authors used a more selective BLASTP homology
search [43]. This observation further highlights the exhaustiveness
of the HMM search.
With regards to the relative abundance of each domain family, a
striking observation is that a high proportion of F-box-carrying
proteins are present in multi-cellular organisms (e.g. 43% in A.
thaliana) while only few of them were identified in apicomplexan
organisms. F-box-containing proteins are adaptor proteins in
Cullin-RING-Ligase complexes (CRLs), and are involved in direct
and specific substrate recognition. Previous authors have hypoth-
esized that the very high number of F-box proteins in A. thaliana
suggests that plants can assemble numerous CRLs, which could
control a wide array of substrates [27]. The low number of F-box
proteins detected in apicomplexan parasites could indicate that
there is no need for these specific adaptors, or that their amino
acid sequences are highly divergent from other eukaryotic cells
and could not be detected using our standard HMM search. An
alternate hypothesis is that a different family of proteins in
apicomplexa could carry out the role of adaptor.
To investigate the global degree of conservation of the predicted
UPS proteins, an all-against-all blast search was performed for
each domain studied and between the 13 genomes analyzed. The
bit scores obtained were reported as a color scale (from red,
‘‘highly divergent’’; to blue ‘‘highly conserved’’) in triangular
distance matrices. Results of this analysis are shown in figure 2.
Using this methodology it is particularly straightforward to realize
that ubiquitin/ubiquitin-like activating enzymes and ubiquitin-
conjugating enzymes are conserved in all eukaryotic cells including
apicomplexan parasites. HECT-ubiquitin ligases and Cullin-
ubiquitin ligases are also well-conserved, while RING and
RING-like ubiquitin ligases, U-box ubiquitin ligases and ubiquitin
ligase adaptors F-box show more diversity. This is particularly
striking with regards to RING/RING-like ubiquitin ligases and F-
box adaptor proteins where almost every protein considered in our
study is divergent from all others, with the exception of U-box,
RING/RING-like-containing proteins from A. thaliana. In this
case, diversity intra-species is much lower than in any other
species. The biological significance of this observation remains to
be elucidated.
With regards to the eight subclasses of DUBs analyzed, the
Josephins (MJD), UCHs (peptidase_C12), autophagins (peptida-
se_C54) and deSUMOylases (peptidase_C48) families are well
conserved within and between species with the exception of a clear
differential expansion in the A. thaliana UCHs and deSUMOylases.
In the other subclasses, relative divergences exist within and
between species. An increased divergence can be observed in the
metalloprotease (JAMM/Mov 34). The function of the WLM
family, usually found only in plant and fungus, in Plasmodium and
Toxoplasma thus deserves to be fully investigated.
When possible, the complete dataset was used to predict
apicomplexan functional homologs of known UPS components
from data available from the five model organisms investigated
here. For each domain, dendrogram trees were built with all the
13 species that we used in this study. For purpose of clarity, only
apicomplexan data are presented here. However, our complete
results are available for download on the laboratory website
(http://lerochlab.ucr.edu/UPS_prediction_data). Figure 3, 4, 5
and 6 show the apicomplexan data for ubiquitin/UBLps, E1, E2,
and E3-Ubox enzymes respectively. The rest of the apicomplexan
data for the other domains are given in supplemental figure S1.
Ubiquitin and ubiquitin-like proteins
Ubiquitin is a 76 amino acid protein extensively conserved
between all eukaryotic sequences, with similarities in excess of
98% between humans, yeast and apicomplexan parasites [43,44].
UBLPs generally bear little primary sequence identity to ubiquitin
(figure 2), however they share two principle features. First is a
compact tertiary structural motif consisting of five beta-sheets and
a single alpha helix, termed the ubiquitin fold, in addition to a low
complexity C-terminus available for activation and conjugation.
Second is a shared biological function through activation,
conjugation and reversible modification of a target protein’s
activity. Since first identification of the first UBLp (the interferon
stimulated gene 15, ISG15) in 1979 additional UBLps (at least 10
to date) have been described with an escalating frequency and
evidence of UBLps ever-widening role in the modification of
cellular processes [17,23]. Paralogs for polyubiquitin, two
ubiquitin-ribosomal protein fusions (Ub-S27a and Ub-52), neural
precursor cell expressed developmentally and down-regulated 8
(NEDD8), small ubiquitin-related modifier (SUMO), homologous
to ubiquitin 1 (HUB1), ubiquitin-related modifier 1 (URM1) and
autophagy 8 (ATG8) have been described in most of the
apicomplexans investigated here (figure 3) [43,44]. The fact that
there are missing paralogs more likely reflects the quality of the
genome sequence available for the different apicomplexan species
(depending upon the status and fold-coverage of their genome
projects) rather than absolute absence from the genome. For
example, several incomplete sequences from the murine malarial
parasites (P. chabaudi and P. yoelii) contain partial ubiquitin
sequences; however it was impossible to definitively assign the
final ubiquitin gene based on the sequence available. In addition to
ubiquitin/UBLps, several genes were identified by the HMM
search that contain the highly related ubiquitin-binding domain
(UBD). These typically N-terminal located domains are found in
proteins that have evolved to adopt the ubiquitin domain in a non-
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Figure 2. Color matrix representation of by-domain diversity for the 13 proteomes. For each domain, BLASTALL (BLASTP) was run with
data from the 13 genomes. Normalized bit scores were plotted following a color scale ranging from ‘‘0=red=very different’’ to ‘‘1=blue=identical’’.
All matrices are triangular. Black lines delimit species, with their respective initials are written on each side of the matrix. For each matrix, the order of
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PLoS ONE | www.plosone.org 6 June 2008 | Volume 3 | Issue 6 | e2386conjugated role in processes such as signal transduction and
proteasomal delivery [45]. These proteins (including paralogs of
yeast RAD23 and DSK2) were manually edited from the list of
ubiquitin/UBLps for all the organisms investigated.
As in all eukaryotes, ubiquitin is encoded by one of three types
of fusion-protein precursors in the apicomplexans investigated
here (figure 3). Although multiple copies of these genes may exist
in higher eukaryotes, only single copies were identified in
apicomplexans. The first type, polyubiquitin, consists of three to
five direct repeats of the ubiquitin coding sequence. The two
remaining ubiquitin-fusion genes encode N-terminal ubiquitin
fused to one of two ribosomal proteins (S27a and S52). In all cases,
subsequent proteolytic cleavage of the polypeptide encoded
releases the ubiquitin monomers. A suitable steady state level of
available ubiquitin monomers is provided by de novo synthesis of
ubiquitin and recycling of ubiquitin following cleavage from their
target proteins. During periods of stress, elevated demands for
ubiquitin are met, in part, by increased levels of polyubiquitin
expression [46]. Expression data available for P. falciparum
indicates all three ubiquitin genes are expressed throughout the
parasite’s life cycle [7,9], while polyubiquitin also appears to be
induced during a heat-shock response [44,47].
Reversible modification by SUMO is generally associated with
processes involving nuclear integrity and function, and more
specifically with nuclear transport, subnuclear targeting and
genome stability (for review see [48]). More recently, conjugation
by SUMO has been suggested to play an additional role of
antagonizing the effect of ubiquitin conjugation–an evolution that
appears to suggest a complex interplay of protein modification
above that of simply activating and inactivating a protein [49,50].
Although not identified in all Plasmodium spp., single copies of genes
encoding SUMO have been identified across all the apicomplexan
organisms investigated here (figure 3). While higher eukaryotes
typically have three to four variants of SUMO, like most single-
celled eukaryotes apicomplexans only have one SUMO variant.
These appear most similar to SUMO-1 in that they lack an
Hub1 Hub1
Ub S27a fus Ub S27a fus
Ub 52 fus Ub 52 fus
PolyUb PolyUb
Nedd8 Nedd8 SUMO SUMO
Urm1 Urm1
Atg8 Atg8
Figure 3. Dendrogram tree of ubiquitin and ubiquitin-like modifiers in Plasmodium spp., Cryptosporidium spp. and T. gondii.
doi:10.1371/journal.pone.0002386.g003
the species is the following (from left to right or top to bottom): P. falciparum (Pf), P. vivax (Pv), P. yoelii (Py), P. chabaudi (Pc), P. berghei (Pb), T. gondii
(Tg), C. parvum (Cp), C. hominis (Ch), S. cerevisiae (Sc), C. elegans (Ce), D. melanogaster (Dm), H. sapiens (Hs), A. thaliana (At). When the space did not
allow writing initials for all species, the first and the last in the succession were indicated separated by dots.
doi:10.1371/journal.pone.0002386.g002
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y represents a hydrophobic residue and K the targeted lysine),
suggesting that polysumoylation does not have a functional role in
apicomplexans. Thus, only ubiquitin, by virtue of multiple internal
modifiable lysines is capable of forming conjugated polymeric
chains on target proteins.
NEDD8, also termed related to ubiquitin 1 (RUB1), is most
similar to ubiquitin at the primary sequence level. NEDD8
typically accumulates in the nucleus where its only known target,
cullin, is found [51]. As described later, cullins form the scaffold for
the SCF (Skp-Cul1-F-box) E3 ubiquitin ligase complexes [52].
NEDD8 appears to play an essential role in cell cycle control in
actively proliferating cells and is down-regulated during cell
differentiation [53]. Single genes encoding NEDD8 were identified
in all apicomplexan families investigated here (figure 3), branching
closely with all the ubiquitin-fusion genes as would be expected
given the higher primary sequence similarity of this UBL modifier.
Single copies of genes encoding the less characterized UBLps
URM1 and HUB1 are found throughout the apicomplexan
lineages investigated here (figure 3). Both UBLps have only been
recently discovered [54,55], and little is known about their
biological roles. HUB1 is noteworthy for the absence of the typical
di-glycine C-terminal motif common to most UBLps, rather
having a di-tyrosine motif. As yet, E1 and E2 proteins that would
activate and conjugate HUB1 have not been characterized and
recent reports suggest that a more ‘‘hormonal’’ role may exist in
higher eukaryotes [56]. However, in S. cerevisiae, conjugation to
proteins involved in mRNA and pre-mRNA splicing have been
described, and may more likely reflect the role of HUB 1 in
apicomplexans [55]. The second UBLP, URM1, shares very little
homology to ubiquitin, but appears more closely related to the
Escherichia coli sulphur carring proteins ThiS and MoaD involved
in thiamin and molybdopterin synthesis, respectively [54]. In S.
cerevisiae, URM1 has only been found to conjugate to alkyl
hydroperoxide reductase 1 (AHP1), suggesting some role in
adaptation to oxidative stress may similarly operate in apicom-
plexans [57].
The autophagy system facilitates degradation of the cytoplasm
following engulfment in a vesicle followed by fusion to lysosomes, a
process necessary for both cell differentiation and response to
UBA4 UBA4
UBA3 UBA3
UBA2 UBA2
UBA1 UBA1
UBA1-like UBA1-like
UBA1-like UBA1-like
Atg7 Atg7
Figure 4. Dendrogram tree of ubiquitin and ubiquitin-like activating enzymes in Plasmodium spp., Cryptosporidium spp. and T. gondii.
doi:10.1371/journal.pone.0002386.g004
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identified two UBLps involved in this system, termed ATG8 and
ATG12 [58]. Previous analysis of several apicomplexan and
kinetoplast genomes highlighted that while a gene encoding ATG8
could be readily identified across a range of protozoa [43], no
evidence exists for the gene encoding ATG12 (see figure 3).
ATG12 plays a key role in the initial formation of the
autophagosome, while ATG8 is conjugated to the amide group
of phosphatidylethanolamine in the membrane, altering the
membrane dynamics; thus, ATG8 is unique amongst UBLps in
not conjugating a protein. Interestingly, while ATG12 has not
been found in kinetoplastids, autophagy has been demonstrated to
be active in Leishmania spp. and play a key role in parasite virulence
[59]. The Pfam search described here identified a single gene in P.
falciparum as being an ATG12 paralog (table 1, PF14_0779).
However, though the predicted polypeptide shares some primary
sequence homology to ATG12 from C. elegans, it lacks a C-terminal
glycine. Further, the cognate E2 and target proteins for ATG12,
ATG10 and ATG5, respectively, are absent from P. falciparum (as
well as the other apicomplexans investigated).
A number of UBLps typical of higher eukaryotes (ISG15,
FAT10, UFM1, FUB1) have not been found in this analysis, nor
that previously described by Ponder and Bogyo (2007). Although
some UBLps may not be expected based on their predicted roles in
immune system regulation in higher eukaryotes, their absence,
coupled with that of SUMO variants and ATG12 in apicomplex-
ans suggest a more restricted role for UBLps in apicomplexan cell
biology. However, analysis of gene expression data (microarray
and proteomics) for SUMO, NEDD8, HUB1, URM1 and ATG8,
where available (particularly for P. falciparum and T. gondii), suggests
that these UBLps are expressed at all the life stages investigated.
These data suggest that ubiquitin/UBLps are essential compo-
nents in controlling cellular processes throughout apicomplexans
complex parasitic life cycles.
Ubiquitin/UBL activating enzymes (E1)
The first step in the ubiquitin/UBLps activation and conjuga-
tion cascade is mediated via E1 proteins. A number of isoforms of
E1 exist, each responsible for the activation of different ubiquitin/
UBLps (for review see [60]). All E1s, however, share a common
UBC13 UBC13
UEV UEV
UBC12 UBC12
UBC9 UBC9
Figure 5. Dendrogram tree of ubiquitin and ubiquitin-like conjugating enzymes in Plasmodium spp., Cryptosporidium spp. and T.
gondii.
doi:10.1371/journal.pone.0002386.g005
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adenylation of the C-terminus of the cognate ubiquitin/UBLp,
which is then held in a non-covalent interaction until subsequent
attack by an active site cysteine resulting in covalent attachment of
the ubiquitin/UBLp via a thioester bond. The final step in the
mechanism is the transfer of the activated ubiquitin/UBLp to E2
via a transesterification reaction.
E1 proteins are characterized by the presence of the ubiquitin
activating (UBA) Pfam domain. Additional motifs in E1 are
responsible for the correct selection of ubiquitin/UBLp for
activation and subsequent E2 to which transfer the activated
ubiquitin/UBLp [61]. Whereas the E1 responsible for ubiquitin
activation (homologous to UBA1 of S. cerevisiae) can deliver
activated ubiquitin to several E2 isoforms, the E1s responsible for
activating the UBLps SUMO and NEDD8, termed UBA2 and
UBA3, respectively, only transfer to a single cognate E2 (see
below). UBA1 has two UBA domains on a single polypeptide.
UBA2 and UBA3, each only have one UBA domain containing
the active site cysteine required for the covalent attachment of
activated SUMO and NEDD8, and actually represent one part of
a E1 heterodimer complex with AOS1 or APPBp1, respectively
[60]. Both AOS1 and APPBp1 each contain one UBA domain,
thus resulting in an E1 complex with two UBA domains. The
analysis presented here indicates the presence of paralogs for
UBA1, UBA2 and UBA3 in all the apicomplexan lineages
(figure 4). High level of primary sequence identity in the core of
the UBA domains present in UBA1-3 is conserved across all
thirteen eukaryotes described in this analysis (figure 2). However,
outside of this core homology, sequences diverge rapidly as the
functional requirements for these sequences in specifically
interacting with different ubiquitin/UBLps and E2 proteins alter.
Assigning paralogs for AOS1 and APPBp1 has not been possible
here–although unassigned proteins containing UBA domains are
present in all apicomplexans investigated here and may well
represent functional paralogs for these proteins. Analysis of
transcriptional patterns in P. falciparum of UBA2 and UBA3 with
those of the unassigned UBA containing proteins, as well as
searching for existing characterized yeast two hybrid interactions,
UFD2 UFD2
PRP19 PRP19
CHIP CHIP
Figure 6. Dendrogram tree of ubiquitin and ubiquitin-like conjugating enzymes in Plasmodium spp., Cryptosporidium spp. and T.
gondii.
doi:10.1371/journal.pone.0002386.g006
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paralogs [62].
In addition to those described above, three additional E1 proteins
are indicated in figure 4. The first, UBA4, is responsible for
activation of URM1. Interestingly, UBA4 has only a single UBA
motif, but does have a rhodanese homology domain (RHD) [63].
Rhodanese and RHD containing enzymes are responsible for
sulphur transfer reactions and form a persulphide bond on their
active site cysteines. Interestingly, an E2 for URM1 has not been
identified to date, and it is suggested that the RHD may act as a
substitute in-built E2 in the transfer of URM1. The second E1,
ATG7, is the only E1 that is capable of activating more than one
UBL modifier–ATG8 and ATG12 [64], however, as described
above, ATG12 does not appear to be present in the protozoa
lineage. ATG7 is characterized by a single C-terminal UBA domain
with a large N-terminal ATG7 specific motif. The final E1 isoform,
termed UBA1-like (due to presence of two UBA motifs), tend to be
larger than Uba1. In several eukaryotes, two or more isoforms of
ubiquitin E1 exist, however, whether these UBA1-like E1s represent
a second ubiquitin E1 or are required for transfer of a different UBL
modifier (note no E1 for HUB1 has been assigned should it actually
have a conjugating role) remains to be determined.
Proteomic and transcriptomic profiling data available for P.
falciparum provide extensive evidence for the ubiquitous expression
of E1s throughout the parasite’s life cycle [7,9]. Interestingly,
detailed analysis of transcription during intraerythrocytic devel-
opment suggests a temporal pattern of transcript accumulation in
the early trophozoite stages when the parasite becomes more
metabolically active. Similar data available for T. gondii similarly
suggest constitutive expression of E1s throughout apicomplexan
life cycles.
Ubiquitin/UBL conjugating enzymes (E2)
Eukaryotes express a number of E2 isoforms, typically of
between 17–22kDa (see [65] for review). E2s are readily identified
by the presence of a conserved central 150-residue domain that
forms a tertiary structure where the cysteine in the active site,
which accepts the activated ubiquitin/UBLp from E1 via a
transesterification reaction, is buried in a shallow groove [66]. The
extensive conservation exhibited by the E2 proteins identified in
the search of the 13 genomes described here is readily exemplified
in figure 2.
The apicompexan parasites investigated here have eight to
fourteen E2 proteins, similar to the 14 described for the only other
single cell eukaryote S. cerevisiae (table 1). The number of E2
isoforms tends to increase with increasing genome complexity.
Given the relative completeness of the Cryptosporidium spp. genomes,
the relative small number of E2 identified in C. hominis and
C.parvum, eight and eleven, respectively, may suggest that these
represent a true variation from the mean of 13 to 14 E2s found in
Plasmodium spp. and T. gondii. Specifically, two E2 variant paralogs
immediately adjacent to the UEV branch in figure 5 (containing
the P. falciparum genes PF14_0128 and MAL13P1.227) are only
found in Plasmodium spp. and T.gondii in this analysis and are
atypical E2s of up to 54kDa with a long N-terminal extension. N-
and C-terminal extensions in E2 are thought to play key roles in
recognition and association with E3s and their subsequent protein
target and thus these atypical E2s may reflect a specific adaptation
in the Plasmodium and Toxoplasma lineages.
Different isoforms of E2 have distinct roles in regulating
downstream functions through specific interaction with distinct
E3s ([22] for review and [67]). While several E2s are capable of
cascading activated ubiquitin through to different E3s, only single
E2 isoforms conjugate to SUMO and NEDD8; UBC9 and
UBC12, respectively. Paralogs for both UBC9 and UBC12 are
present in all the apicomplexan lineages investigated here (figure 5).
One isoform of E2, termed the Ub-E2 variant (UEV), lacks both a
key HPN amino acid motif and the active site cysteine in the E2
core and is incapable of conjugating ubiquitin. UEVs instead form
a heterodimer with the UBC13 E2 isoform and direct a subset of
E3s to conjugate ubiquitin to its target through the side chain of
Lys63 (as opposed to more typical conjugation through the side
chain of Lys48) [50]. Paralogs for both UBC13 and a UEV are
present in all the apicomplexan lineages investigated here (figure 5).
Conjugation of ubiquitin through Lys63 generally acts as non-
proteolytic signals for processes such as DNA repair [49]. Thus,
proteins may be conjugated by polyubiquitin chains, single ubiquitin
molecules through more than one lysine side chain and even
competitively with SUMO. This diversity of conjugation has
important implications in post-translational modifications directing
a diverse response in the target protein. Interestingly, strong yeast
two-hybrid data in P. falciparum indicates a clear association of the
UBC13 and UEV paralogs in this organism [62]. One E2 molecule
not reported in this analysis is ATG3, which is responsible for
conjugation to the UBLp ATG8. This E2 exhibits extreme diversity
to that of other E2s and lacks the core E2 Pfam motif used in this
analysis. Paralogs exist in all apicomplexans investigated here
(PFI0280c, PB000344.03.0, PC000563.02.0, Pv098725, PY04567,
chro.80308, cgd8_2650 and 46.m01688).
Extensive gene expression data for nine of the fourteen P.
falciparum E2s suggest a diverse pattern of steady state mRNA
accumulation at different stages of intraerythrocytic development.
The fact that different E2 isoforms are expressed at distinct stages
in the parasite’s life cycle suggests that a temporal profile of
delivering ubiquitin/UBLps to different E3s exists, which
highlights a potential additional level of temporal control in the
UPS system during apicomplexan parasite’s life cycles.
Ubiquitin/UBL ligases (E3)
E3 ubiquitin/UBL ligases are a very diverse group of proteins
involved in specifically transferring ubiquitin/UBLps to a given
substrate. In all organisms, 48% of the predicted UPS components
identified belong to the E3 ubiquitin/UBL ligase family. This high
percentage of E3 reflects the specificity that is required for specific
substrate recognition. Table 2 summarizes all potential E3
ubiquitin/UBL ligases that have been found in P. falciparum, and
their homologs in T. gondii, C. parvum, and yeast. There are three
superfamilies of E3 ubiquitin/UBL ligases. HECT ubiquitin
ligases have a direct role in catalysis during ubiquitylation,
whereas RING (Really Interesting New Gene) finger and U-box
E3s are involved in multi-protein complexes. RING finger E3s are
the most abundant ubiquitin/UBL ligases.
Our search identified four HECT domain-containing proteins
in P. falciparum, and other apicomplexans. Three of them have a
homolog in S. cerevisiae: TOM1, UFD4, and HUL5 (HUL5 has
unknown functions). The fourth HECT-domain protein that we
identified in apicomplexans does not match any protein from yeast
but is similar to UPL5 in A. thaliana (see table 2). UPL5 has an
unknown function, but is annotated as potentially involved in cell
proliferation. TOM1 (MAL8P1.23 in P. falciparum, and 86.m00385
in T. gondii) has been recently described as being involved in cell
cycle arrest after DNA damage, mediating CDC6 ubiquitylation, a
protein essential to initiation of DNA replication [68]. UFD4
(MAL7P1.19 in P. falciparum, and 80.m02344 in T. gondii)i s
involved in the ubiquitin fusion degradation pathway (UFD
pathway) [69], which results in polyubiquitylation of ubiquitin
fusion proteins that do not fall into the N-end rule pathway (the N-
end rule relates the in vivo half-life of a protein to the identity of its
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PLoS ONE | www.plosone.org 11 June 2008 | Volume 3 | Issue 6 | e2386Table 2. Annotated list of E3 ubiquitin and ubiquitin-like ligases in P. falciparum, with their homologs in T. gondii, C. parvum and S.
cerevisiae.
Domain P. falciparum T. gondii C. parvum S. cerevisiae Annotation
HECT MAL8P1.23 86.m00385 none TOM1 GO: mRNA transport; similar to UPL1/UPL2 in A. thaliana
HECT PF11_0201 64.m00324 cgd8_1200 HUL5 similar to UPL6/UPL7 in A. thaliana
cgd1_1920
HECT MAL7P1.19 80.m02344 none UFD4 cytoplasmic E3 for degradation of ubiquitin fusion protein
HECT PFF1365c 25.m01837 cgd7_4990 none GO: cell proliferation; UPL5 in A. thaliana
59.m03523
72.m00400
Cullin PF08_0094 80.m02207 cgd4_3150 CDC53 structural protein of SCF complexes
Cullin PFF1445c none none CUL8 possible role in anaphase progression;
U-box PF08_0020 72.m00386 cgd3_2410 UFD-2 ubiquitin chain assembly factor E4; ubiquitin fusion degradation protein
U-box PFC0365W 641.m01564 cgd6_4850 PRP19 splicing factor associated with the spliceosome
U-box PF07_0026 none none none similar to CHIP in A. thaliana and H. sapiens
RING finger PFI0470w none cgd2_2410 SSM4 Deg1 signal-mediated degradation pathway; GO: mRNA turnover and stability
RING finger MAL13P1.405 20.m03749 cgd8_4800 none have homologs in A. thaliana only; unknown function
RING finger PF14_0215 540.m00334 cgd8_2560 none similar to HRD1-like; GO: ERAD pathway
RING finger PFC0510w 50.m05636 cgd7_4170 HRD1 involved in the ERAD pathway
cgd1_1790
RING finger PFE1490c 46.m00026 cgd8_3470 none similarities with RIE1 in A. thaliana (seed development)
RING finger PF10_0276 42.m00120 cgd7_4910 none unknown function
44.m02707 similar to ATL4 in A. thaliana
RING finger PFF0355c 74.m00769 none none unknown function; found in Apicomplexa only
PF14_0054
RING finger PF10_0072 80.m03951 cgd1_1950 none unknown function
RING finger PFF0755c 57.m01707 cgd2_2950 RKR1 GO: chromatine structure
RING finger PFC0740c 57.m01858 cgd4_1360 none unknown function; GO: cell growth regulation
cgd3_1260
RING finger PFL0440c 540.m00204 cgd5_3990 ASI1 with ASI2 and ASI3 ensures the fidelity of SPS-sensor signalling
cgd5_3970
RING finger PFE100w none cgd5_3900 PEX2 component of the CORVET complex
PFI0805w
RING finger PFL1620w none none DMA1 spindle position and orientation
DMA2
RING finger PFC0175w none none YKR017C homologous to ariadne ubiquitin conjugating enzyme binding protein in H.
sapiens
RING finger PFF1325c 20.m03922 cgd2_1820 none unknown function
RING finger PFC0610c 583.m00699 cgd4_4310 PIB1 GO: endosomal trafficking, vacuolar trafficking
RING finger PFF0165c 35.m01589 cgd2_880 BRE1 involved in histone H2B ubiquitination
RING finger MAL7P1.155 none none none unknown function; possible cytoskeleton-related
RING finger PF14_0416 42.m00073 cgd6_3300 CWC24 element of the spliceosome
RING finger PF14_0139 50.m03082 cgd8_3720 none GO: cell proliferation
RING finger PFL1705w 49.m03145 cgd7_4960 YER068W Not-like; component of the CCR4-Not complex
RING finger PFC0425w none none none unknown function; found in Apicomplexa only
MAL13P1.224
RING finger PFL0275w 20.m03824 cgd7_3320 none possible topoisomerase 1
RING finger PFD0765w none none none unknown function
RING finger PF11_0244 20.m03803 none none unknown function; found in Apicomplexa only
RING finger PF10_0046 76.m01590 cgd3_2060 none similar to CIP8 in A. thaliana
RING finger PFF1180w none cgd1_2640 APC11 element of the anaphase promoting complex/cyclosome
RING finger PFC0845c none cgd8_930 RBX1 element of the Skp1-Cullin-Fbox complex
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isoleucine at its N-terminal end will be targeted to the proteasome
more rapidly than a protein with a glycine, which is a stabilizing
residue; see [70] for a review). Little is known about the UFD
pathway, and its physiological functions remain unknown. Recent
works indicate that UFD4 is involved in controlling the
degradation of RAD4, a nucleotide excision repair protein [71].
U-box proteins are another family of ubiquitin ligases that are
structurally similar to RING finger proteins but lack the metal
binding sites (see [26] for a review). A sub-group of U-box proteins
is also termed E4 ubiquitin chain assembly factor, and is known for
its ability to add a polyubiquitin chain on a substrate already
primed for degradation by oligoubiquitylation [72]. We identified
two U-box domain-containing proteins that are present in all
apicomplexan parasites: the S. cerevisiae UFD2 (PF08_0020 in P.
falciparum, and 72.m00386 in T. gondii) and PRP19 (PFC0365w in
P. falciparum, and 641.m01564 in T. gondii) homologs (figure 6).
UFD2 is an E4 ubiquitin ligase, involved in the UFD pathway
[72]. In yeast, UFD2 interacts with the AAA ATPase (ATPase
associated with various activities) CDC48, which possesses a
chaperone-like activity and mediates ubiquitin-dependant endo-
plasmic reticulum associated degradation (ERAD) pathway [73].
Richly et al. [74] proposed a short ubiquitylation chain-dependant
escort pathway to the proteasome that would involve UFD2,
which adds ubiquitin proteins to a substrate already mono- or di-
ubiquitinated. In this escort pathway, the Cdc48-Npl4-Ufd1 would
act to restrict chain length to four to six ubiquitin. CDC48 (p97 in
mammalians) is involved in several different functions in cell, such
as retrotranslocation from the ER to the cytosol (quality control),
transcriptional control or cell cycle regulation (see [75] for a
review). CDC48 is the cyclin-dependant kinase (CDK) that
promotes cell cycle progression in yeast. Previous works indicate
that CDC48 regulates the stability of several cell-cycle regulators
in a UPS-dependant manner. CDC48 was also found to regulate
the stability of proteins involved in controlling the expression of
genes involved in fatty acid metabolism in yeast (see [75] for a
review). We used BLASTP to identify homologs of proteins
involved in the escort pathway and do not carry UPS-related
domains (and are thus absent from our dataset). We predicted
CDC48, Ufd1 and Npl4 in P. falciparum, PFF0940c, PF14_0178
and PFE0380c respectively (see supplemental Table S2). All these
proteins seem to be well conserved in P. falciparum. Furthermore,
clear orthologs of CDC48, Ufd1 and Npl4 are predicted in P. yoelii,
C. parvum, C. hominis, and T. gondii (from OrthoMCL-DB, [76], see
supplemental Table S2). These findings could indicate that the
Ufd2-dependant Cdc48-Npl4-Ufd1 escort pathway exist in P.
falciparum and other Apicomplexa, with functions similar to the
ones observed in yeast.
PRP19 is an oligomeric U-box-containing E3 ligase [77] that
plays a role in mRNA splicing [78], spliceosome activation and
recycling [79,80], and DNA damage response [81]. PRP19 is part
of a complex consisting of at least eight units, of which CDC5 and
PLRG1 (Pleiotropic regulator 1) [78]. Lu and Legerski [81]
demonstrated that, in DNA damage conditions, PRP19 is
ubiquitinated. The authors showed that ubiquitinated PRP19 fails
to interact with either CDC5 or PLRG1, and over expression of
PRP19 reduces the levels of apoptosis after exposure of cells to
DNA damage. Little is known about apoptosis or programmed cell
death in Apicomplexa. Apoptosis-like events have been described
in P. falciparum and P. berghei [82,83]. Al-Olayan and co-workers
suggested that apoptosis could be a possible mechanism for
limiting intensity of infection in the mosquito by P. berghei (see [84]
for review). Unfortunately no data is currently available about the
function or the expression pattern of PRP19 homolog (PFC0365w)
in P. falciparum ookinetes. In T. gondii, the homolog of PRP19
(641.m01564) contains WD40 repeats, which are known to be
involved in a wide array of cellular processes ranging from signal
transduction and transcription regulation to cell cycle control and
apoptosis [85,86]. However, the functions of PFC0365w and
61.m01564 remain to be elucidated.
A third U-box containing ubiquitin ligase, that is absent in
yeast, has been identified in Plasmodium species (PF07_0026 in P.
falciparum) and shares extensive homology with the human protein
CHIP (C-terminal of Hsp70-interacting protein). Like UFD2,
CHIP has been described as being an E4 ubiquitin ligase in
human. A particular feature of CHIP is that its catalytic activity
requires its homodimerization through the U-box domain (see [87]
for review). CHIP is known to be involved in protein quality
control by promoting ubiquitylation of denatured proteins in an
Hsp70/Hsp90-dependant manner. CHIP is also involved in heat
shock response and prevention of apoptosis. However, the
physiological substrates of CHIP still remain unidentified. Previous
experiments suggested that CHIP might have multiple functions
that could be proteolytic either dependent or independent from
proteasome degradation [88]. However, the physiological role(s) of
CHIP remain(s) unknown. In P. falciparum, the CHIP homolog
PF07_0026 is mainly expressed at the sporozoite stage (mosquito
stage). Interestingly we also identified CHIP homologs in P. berghei,
P. chabaudi, P. vivax and P. yoelii (respectively PB001535.02.0,
PC000957.01.0, Pv087910, PY00139) whereas no homolog was
found in yeast Cryptosporidium spp. and T. gondii. Thus, it can be
hypothesized that CHIP homologs in Plasmodium are involved in
Domain P. falciparum T. gondii C. parvum S. cerevisiae Annotation
RING finger PFB0440c 583.m05584 cgd3_3460 none unknown function
RING finger MAL13P1.216 641.m01484 none RAD5 component of the SWI/SNF pathway
RING finger PFL2440w 42.m00128 cgd4_140 RAD16 component of the SWI/SNF pathway
RING finger PF10_0117 none cgd2_1750 none unknown function
RING finger PFE0610c 641.m02557 cgd1_3300 TFB3 component of the nucleotide excision repair pathway
RING finger PF13_0188 none cgd5_1200 none unknown function; found in Apicomplexa only
RING finger MAL13P1.122 none cgd5_400 none unknown function; found in Apicomplexa only
RING finger PFC0690c none cgd7_1170 YDR266C role in partionning of cytoplasm
RING finger PF11_0330 59.m03727 none none possible SUMO ligase
doi:10.1371/journal.pone.0002386.t002
Table 2. cont.
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Cullin-containing proteins belong to the E3 ubiquitin ligase
family. In association with a RING finger E3 and a substrate
recognition protein such as F-box proteins, they form Cullin-
RING-Ligases (CRLs). The most famous CRLs are the Skp1-
Cullin1-Fbox (SCF) complex, containing the cullin protein
CDC53 in yeast, and the Anaphase Promoting Complex/
Cyclosome (APC/C), containing the cullin protein APC2 in yeast.
Both the SCF and the APC/C are involved in cell-cycle
progression (see [89] for review). A homolog to CDC53 has been
found in each apicomplexan (PF08_0094 in P. falciparum, and
80.m02207 in T. gondii). The SCF contains at least four subunits:
CDC53 (Cullin1) which is stabilized by the ubiquitin-like modifier
NEDD8, the RING E3 RBX1, the adaptor protein Skp1 and a F-
box protein for substrate recognition (see [39] for review). The
present study allowed us to confirm the presence of F-box proteins
as well as NEDD8 and RBX1 homologs in apicomplexan genomes
(table 1) (MAL13P1.64 and PFC0845c respectively in P. falciparum,
see figure 3). Using BLASTP, we identified homologs of Skp1 in
the genomes of each apicomplexan (MAL13P1.337 in P. falciparum,
see supplemental table S3). The minimum components that are
required for the cell-cycle regulator SCF are therefore all present
in apicomplexan genomes. The situation is different as far as the
APC/C is concerned. While a homolog to CUL8 and the RING
finger APC11 involved in the APC/C were recognized by our
analysis (respectively PFF1445c and PFF1180w in P. falciparum),
the cullin classically involved in the APC/C (APC2) was not found
in apicomplexan parasites. The role of CUL8 is not well known.
Previous data suggest that it may be involved in anaphase
progression [90] in a CRL other than the classic APC/C. The
presence of a slightly different APC/C in P. falciparum is not
entirely unexpected. Cell division during schizogony is apparently
asynchronous in P. falciparum, that is, several rounds of DNA
replication/DNA division occur before final cytokinesis, instead of
the paradigm of successive cycles of alternating DNA replication/
DNA division/cytokinesis ([91–93]).
RING finger and RING-like E3 ubiquitin ligases are the largest
group of E3s. They do not have a direct catalytic role in linking
ubiquitin and ubiquitin-like modifiers. They rather act as adaptor
partners: RING E3s interact with both an E2 ubiquitin-
conjugating enzyme (that is carrying ubiquitin) and its given
specific substrate, bringing the substrate in close proximity with
ubiquitin. Since RING and RING-like E3s are involved in
substrate recognition, and given the diversity of proteins that are
targeted by the UPS, a large diversity of RING and RING-like
E3s is expected (homologs of RBX1 and APC11 are only two of
the numerous RING and RING-like proteins, up to 55 in T. gondii,
that were functionally identified by our analysis). For example, we
have found potential RAD16, RAD5, and TFB3 homologs
(PFL2440w, MAL13P1.216, and PFE0610c repectively in P.
falciparum, and 42.m00128, 641.m01484, and 641.m02557 repec-
tively in T. gondii), which are known to be involved in nucleotide
excision repair (NER) [94]. Previous work showed that RAD16
mediates histone H3 acetylation before global nucleotide excision
repair [95]. Interestingly, several of the RING E3s that were found
in apicomplexan parasites are potentially involved in mRNA
turnover and stability (PFI0470w in P. falciparum) or pre-mRNA
maturation (PF14_0139 and PF14_0416 in P. falciparum, and
50.m03082 and 42.m00073 in T. gondii) [96]. Consistent with
previous work, this observation suggests that regulation of mRNA
stability is a major mechanism of gene regulation in P. falciparum
[10]. Several others of the identified RING E3s are potentially
involved in histone ubiquitination (e.g. PfBre1 PFF0165c in P.
falciparum, 35.m01589 in T. gondii), or chromatin remodeling and
silencing (PF10_0046 in P. falciparum and 76.m01590 in T. gondii).
Recent data have increasing shown that epigenetic mechanisms
play a key role in the control of gene expression in Apicomplexa.
In Plasmodium, chromatin modeling is one of the proposed
mechanisms that control allelic exclusion of the var virulence
genes [97,98]. In T. gondii, acetylation of histone H4 or acetylation
on lysine 9 of histone H3 as well as trimethylation of lysine 4 of
histone H3 were shown to be located close to the 59 UTR of the
active genes [99]. Increasingly, evidence suggests that the precepts
of the universal ‘‘histone code’’ and the molecular mechanisms
that underpin reversible histone modification similarly applies to
Apicomplexa, although much yet remains to be elucidated.
It is interesting to notice that several RING-domain proteins
found in apicomplexans do not cluster with any other known
protein. In P. falciparum, PF14_0054 and PF13_0188 are two
examples of proteins with no evident homologs in the organisms
analyzed, besides their apicomplexan counterparts. With regards
to their expression profiles [7,9], PF14_0054 is expressed at the
sporozoite and the late schizont stages of Plasmodium’s life cycle,
which suggests that this protein may be specific to apicomplexan
processes such as parasite invasion. However, functions of several
of the predicted parasitic RING and RING-like proteins remain to
be elucidated, either because there are no known homologs in
other model organisms, or because the function of the matching
homolog remain unknown.
Whilst prediction of function based on sequence homology can
be misleading, a study of the domain architecture of RING and
RING-like E3 ligases may highlight additional features. P.
falciparum’s RING and RING-like E3 ligases were investigated
using SMART to predict all protein motifs present([100], see
material and methods). Results are shown in figure 7. This analysis
revealed that P. falciparum RING and RING-like E3 ligases possess
major domain architectures found in E3 ubiquitin/UBL ligases
from other model organisms: an N-terminal or C-terminal RING
domain, a RING domain associated with a zinc finger domain
such as C2H2 domain, the architecture RING/RNA recognition
motif (RRM), RING/helicase, RING/forkhead-associated do-
main (FHA), and RING/in between RING (IBR). It is interesting
to observe that predicted Plasmodium RING E3s with a single
RING domain appear more abundant than those of yeast. Several
of these proteins carry several coiled-coil regions, e.g. up to six in
PFF0165c. Coiled-coil domains are known to be involved in
regulation of gene expression and many other biological processes
(see [101] for a review). The role of coiled-coil domains in host-
pathogen interactions has particularly been studied. The molec-
ular cross talk that occurs between a pathogen and its given host is
complex. The pathogen has to collect and process diverse host
signals in order to modulate the expression of its virulence genes.
In gram-negative bacteria, coiled-coil proteins are involved in type
III secretion systems that are used to deliver virulence effector
proteins into, or close to, the host cell (see [102] for a review). In
Agrobacterium tumefaciens, the histidine kinase VirA activates the
expression of virulence genes in response to multiple wound-
derived plant signals, via the involvement of coiled-coil structures
[103]. The HIV protein gp41 contains a conserved coiled-coil
domain that is critical for the entry of the virus into the host cell
[104]. Thus, the apparent abundance of coiled-coil-containing
RING E3 ligases in P. falciparum may provide a link to the
particular virulence of this parasite and would appear to warrant
further investigation.
RING E3 ubiquitin ligases with one or multiple predicted
transmembrane domains are also more abundant in P. falciparum
than in yeast (ten and three proteins, respectively). Membrane
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regulation of immune recognition during virus infections (see [105]
for a review). The abundance of such RING E3 ubiquitin ligases
would be of obvious interest in understanding how chronic
infections are established during infection by these parasites.
DUBs and DUBLs enzymes
DUBs are responsible for generating ubiquitin precursors from
fusion protein and polyubiquitin chains. They are involved in the
disassembly of polyubiquitin chains for the maintenance of the
available ubiquitin within the cell. DUBs are also responsible for
the editing of ubiquitin conjugates to alter their commitment for
proteolysis [28,106]. In these roles, DUBs have been shown to be
associated with proteasome subunits [107,108]. A second
important pathway associated with deubiquitylation is the control
and degradation of membrane protein trafficking to the vacuole/
lysosome [109–112]. Furthermore, DUBLs have been shown to
play additional key roles in eukaryotic cells. For example, the
SUMO deconjugating enzymes (also termed SENPs) play a role in
the control of transcription [113], the autophagy-related DUBLs
similarly regulate vacuole targeting pathways [114,115] and the
WLM family is thought to be specifically involved in desumoyla-
tion and chromatin structure maintenance [29]. Increasing data
indicate that most DUBs/DUBLs regulate a limited number of
specific substrates, where they interact either directly with
ubiquitin/UBLp, or with the target protein to which ubiquitin/
UBLp is conjugated.
Between 20 to 40 DUBs and DUBLs were found in
apicomplexan genomes (table 1), while 165 were detected in A.
thaliana. Moreover, most of the major DUBs and DUBLs
subfamilies were found within each of the apicomplexan genomes.
The few exceptions in P. chabaudi and P. berghei are probably the
consequences of weak genomic sequences coverage for these two
apicomplexan species.
UCH-L3, which was identified in all Apicomplexa, is known to
cleave ubiquitin and the UBLp NEDD8. The first active DUBs
(UCH-L3 and UCH-L5) were recently identified in P. falciparum
and T. gondii, and showed to both react with ubiquitin and
NEDD8 [116,117]. SUMOylases (SENPs), of which at least two
are present in apicomplexan genomes, are known to be SUMO-
specific proteases but have also been shown in some cases to cleave
NEDD8. UBLps, such as ATG8 involved in autophagy, are also
processed by distinct proteases, such as the Autophagin peptidase
C54, of which one isoform has been identified in all Apicomplexa
investigated here.
Determination of target specificity in vivo has been challenging in
other model organisms. It is possible that in vivo protein
localization and the presence of adaptors such as E3 ligases can
increase specific interactions [118]. Despite the challenge of target
identification, the function of several DUBs have been clearly
identified and implicated in critical cellular process. The fact that
all DUBs subclasses are present in apicomplexans suggests that
several of their functions are conserved. For example, deubiqui-
tination of proteins at the proteasome lid is necessary for protein
degradation and recycling of ubiquitin. Various DUBs, such as the
metalloprotease JAMM (RPN11 and RPN8 in yeast) the UBP6 in
yeast or UCH-L5 in mammalian, have been found in complex
with proteasome subunits.
Increasing evidence suggests that several DUBs are implicated
in remodeling chromatin structure, transcriptional regulation and
gene silencing. In yeast, UBP8 and UBP10 have been implicated
in the dynamic histone monoubiquitination of H2B. The presence
of UBP8 correlates with changes in transcriptional regulation
[118] whilst UBP10 is required for the recruitment of the silencing
factor Sir2 [119]. Both of these DUBs have homologs in
Apicomplexa (eg. PFI0225w and PF14_0145 in P. falciparum,
respectively) and could be potentially involved in the regulation of
parasite virulence genes, principally the var gene family in P.
falciparum.
DUBs are also implicated in the endocytic pathway and
intracellular traffic [112]. JAMM and USP proteases (AMSH
and USP8 in human) as well as the human OTU (VCIP135)
protease have all been shown to have a role in endocytosis and
vesicle assembly, respectively. Whether their homologs share the
same function in trafficking in Apicomplexa warrants further
interest. However, recent studies in antimalarial drug resistance
have identified a strong genetic association between drug
resistance in Plasmodium and a locus containing a DUB related to
USP7 [120]. Further studies will be required to validate the
potential role of DUBs in the evolution of parasite drug resistance.
Expression profiles analysis [7,9] reveals that all the putative
DUBs/DUBLs identified here were expressed in at least one stage
of the P. falciparum life-cycle, providing additional evidence for a
functional role in the parasite’s life cycle.
Conclusion
The present study allowed for the identification of up to 114
proteins that are predicted to be involved in the UPS of P.
falciparum and other Apicomplexa. All apicomplexans possess the
complete machinery that is required to ubiquitylate proteins (i.e.
ubiquitin and ubiquitin-like modifiers, E1 enzymes, E2 enzymes,
E3 enzymes, and deubiquitinases). Ubiquitin and the common
UBL modifiers SUMO, NEDD8, HUB1, URM1, and ATG8
were identified in apicomplexans. However, several UBLps are
missing, such as SUMO variants and ATG12, although it has been
suggested that autophagy is one of the parasite’s death pathway
[121]. Further investigations are required to elucidate the role of
UBLps in apicomplexan biology. Our results also highlighted
apicomplexans-specific features in enzymes involved in transfer-
ring ubiquitin and UBL modifiers to a target substrate. For
example, two E2 variants found only in P. falciparum and T. gondii
have up to triple the molecular weight of E2s found in other
organisms, which could reflect adaptation of Plasmodium and
Toxoplasma lineages. Finally, the superfamily of E3 ubiquitin ligases
with the Coils2 program, and signal peptides are predicted with the SignalP program. Legend: RING=RING finger; RINGv=C4HC3 RING-variant;
IBR=in between RING fingers; ZnF_UBP=Ubiquitin Carboxyl-terminal Hydrolase-like zinc finger; ZnF_UBR1=Putative zinc finger in N-recognin, a
recognition component of the N-end rule pathway; PHD=plant homeodomain zinc finger; ZnF_NFX=zinc finger domain repressor of transcription;
ZnF_C3H1=zinc finger domain; ZnF_C2H2=zinc finger domain; DEXDc=DEAD-like helicases superfamily; HELICc=helicase superfamily c-terminal
domain; R3H=Putative single-stranded nucleic acids-binding domain; FYVE=zinc finger present in Fab1, YOTB, Vac1, and EEA1; WD40=WD40
repeats; RRM=RNA recognition motif; FHA=Forkhead associated domain; SAP=Putative DNA-binding (bihelical) motif predicted to be involved in
chromosomal organisation; Pfam MAT1=CDK-activating kinase assembly factor MAT1; Pfam BRE1=CDK-activating kinase assembly factor MAT1;
Pfam HIRAN=HIP116, Rad5p N-terminal domain, found in the N-terminal regions of the SWI2/SNF2 proteins; Pfam BRAP2=BRCA1-associated protein
2; Pfam Pex2-Pex12=Pex2/Pex12 amino terminal region; Pfam ClpS=ATP-dependent Clp protease adaptor protein ClpS; Pfam SPX=SYG1, Pho81
and XPR1 domain; Pfam zf-UBR=Putative zinc finger in N-recognin (UBR box); Pfam zf-MIZ=MIZ/SP-RING zinc finger. The grey bar represents the
primary structure of proteins.
doi:10.1371/journal.pone.0002386.g007
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do not find homolog in other eukaryotic organisms. Such proteins
could have a cellular role directly linked to parasitic processes,
such as invasion. The over-representation of RING E3 ligases that
contain coiled-coil domains, known to play important role in host-
pathogen interactions, supports this hypothesis.
An example of apicomplexan adaptation in the UPS is an
apparently modified APC/C (called APC-related). In yeast, SCF
and APC are known to play a fundamental role in cell-cycle
control. All proteins known to be involved in the SCF machinery
are present in the Plasmodium genome. The presence of a modified
APC complex in the atypical erythrocytic Plasmodium cycle is not
surprising. The cell cycle in Plasmodium can be closely related to the
early embryogenesis division observed in D. melanogaster with a
depletion of key cell cycle regulators. During the first 13 cell
divisions of a D. melanogaster zygote, the divisions are rapid,
synchronous and occur in the absence of cytokinesis and
detectable gap phase. These divisions result in the formation of
a syncytial cell containing a large number of nuclei in a single
cytoplasm. In Plasmodium, divisions during schizogony are rapid
and asynchronous with up to four or five rounds (four rounds
equals 16n and five rounds equals 32n) of DNA synthesis and
mitosis during the trophozoite and early schizont stages.
Cytokinesis takes place late in the cycle during the mature
schizont stage. This is a major divergence from the classical cell-
cycle events that consists of a linear succession of G1/S/G2/M
phases. A proposed model for the Plasmodium cell-cycle control is
presented in figure 8 where the classical SCF complex could be
involved in the control of the checkpoint between the gap G1 and
S phase. The expression profile of the cullin analogue (highly
expressed in the trophozoite and schizont stages) potentially
involved in the parasite SCF complex reinforces this hypothesis. It
will then be expected that the modified APC complex could
regulate the atypical parasite cytokinesis. Interestingly, proteasome
inhibitors have been shown to block parasite cell-cycle progression
at the ring and late schizont stage [122]. These observations help
validate the hypothesis of two major parasite cell-cycle checkpoints
at the G1/S and the cytokinesis phases.
The number of genes that our work predicted to encode
components of the UPS in Plasmodium and other apicomplexa is a
good estimate when compared to other eukaryotic organisms. Our
results demonstrate that E3 ubiquitin/ubl ligases remain one of the
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complexes in P. falciparum. Identifiers from PlasmoDB are given in parenthesis.
doi:10.1371/journal.pone.0002386.g008
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and diverse E3s, and in particular RING domain-containing
proteins, suggests that target-specific ubiquitylation via E3 ligases is
a complex and important part of cellular regulation in eukaryotic
cells, including apicomplexan parasites. In terms of sequence
homology, when counterparts exist, most of the ubiquitin ligases
identified in Apicomplexa display divergences from their human-
host counterpart. The domain architecture analysis for P.
falciparum’s RING finger E3s revealed an abundance of coiled-
coil domain. Since such domains have been shown to play a major
role in signal transduction during the molecular cross-talk that
occurs during a viral or a bacterial infection, our hypothesis is that
E3 ubiquitin/UBL ligases in P. falciparum and other Apicomplexa
are involved in pathogen virulence and/or pathogenicity.
The potential to treat apicomplexan parasites via drugs that
target the proteasome component of the UPS has been established
in P. falciparum. However, this potential to exploit these drugs is
limited. The latest generations of drugs that target the UPS have
focused more on the specificity of the action of E3 ligases and
DUB/DUBLs. Given the apparent apicomplexan diversity in
these proteins, opportunities to develop small molecule inhibitors
specific against the the apicomplexan-specific E3 ligase and DUB/
DUBLs offer some possibility for new, much needed, therapeutics
for these devastating global diseases.
Materials and Methods
Proteome and domain motifs datasets
Full proteome datasets from the following thirteen organisms
were downloaded: P. falciparum, P. vivax, P. yoelii, P. berghei, P.
chabaudi, C. parvum C. hominis, Toxoplasma gondii, S. cerevisiae, C.
elegans, D. melanogaster, A. thaliana and H. sapiens. Additional
information regarding data sources and release information are
given in table S4. Twenty-four Pfam motifs, found throughout the
UPS, were selected (focusing on ubiquitin and UBLp, E1 and E1-
like enzymes, E2 enzymes, E3 and E3-like enzymes and DUB/
DUBL enzymes). Their Pfam HMM profiles were downloaded
from the Pfam_ls HMM library version 22.0 [123] at http://pfam.
janelia.org (Pfam accession numbers: ubiquitin, PF00240; APG12,
PF04110; MAP1_LC3, PF02991; UPF0185, PF03671; Urm1,
PF09138; UBACT, PF02134; ThiF, PF00899; UQ_con, PF00179;
zf-C3HC4, PF00097; zf-RING-like, PF08746; zf-MIZ, PF02891;
Cullin, PF00888; U-box, PF04564; F-box, PF00646; HECT,
PF00632; Josephin, PF02099; Mov34, PF01398; OTU, PF02338;
DUF862, PF05903; WLM, PF08325; Peptidase C12, PF01090;
Peptidase C48, PF02902; Peptidase C54, PF03416; UCH,
PF00443).
Protein identification using HMM search
Components of the HMMER 2.3.2 package (released in
October 2003) were used throughout the study [124]. This
software can be freely downloaded from http://hmmer.janelia.
org. The program hmmsearch was used to analyze domain
distribution among all proteome datasets and to extract sequences
that carry the Pfam domains described above. HMM searches
were run using a series of incrementally increasing threshold E-
values, from E-value #1 to E-value #0.1, and results were
checked for false positives. Threshold E-value #0.5 gave the best
quality results, and thus was used in the present study.
Building colored distance matrices
Proteins carrying same domain motifs were pair aligned by
BLASTP. Output bits scores were used as protein distance values:
the higher the values are, the more proteins are similar and
therefore could be evolutionary closed. All scores below 20 were
set to 20. Values were scaled in the range [0,1] by normalizing
using a global transformation (d=minimum score/score). A color-
mapping matrix, from red to blue, was built, using MATLABH 7,
from the normalized scale. The red color means ‘‘highly
divergent’’, and blue means ‘‘highly conserved’’.
Building dendrogram trees
Protein sequences were aligned using ClustalW [125]. For each
protein family, bootstrap parameters were set to 10 times the
number of proteins in the set; for example, a set containing 100
proteins was boostrapped 1000 times. Dendrogram trees were
generated from ClustalW multiple alignments, using the maxi-
mum likelihood method in the PHYLIP package [126]. Trees
were visualized with MEGA4 [127] and manually annotated.
Domain architecture of the predicted RING and RING-like
E3 ubiquitin ligases
Our datasets of P. falciparum and yeast RING and RING-like E3
ubiquitin ligases were searched for functional domains using
SMART [100]. Our dataset from yeast was used as a reference.
Supporting Information
Table S1 Exhaustive list of the proteins identified by the HMM
search.
Found at: doi:10.1371/journal.pone.0002386.s001 (0.37 MBXLS)
Table S2 Components of the Cdc48-Npl4-Ufd1 escort pathway
in P. falciparum, predicted by BlastP, and their orthologs retrieved
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Found at: doi:10.1371/journal.pone.0002386.s003 (0.03 MBXLS)
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